Patient | Tumor site | Year of diagnosis | Chemotherapy | Radiotherapy |
---|---|---|---|---|
2 | Lung | 1989 | Ifosfamide (1800 mg /m2/day) and VP16 (100 mg/m2/day) | 60.4 Gy |
3 | Sternal mass | 1996 | aCCG 0894: carboplatinum (400 mg/m2/day), VP16 (100 mg/m2/day) and ifosfamide (1800 mg /m2/day) Autologous peripheral hematopoietic stem cell rescue with melphalan (200 mg/m2). | 60.4 Gy |
4 | Nasopharynx | 1996 | aCCG 0894: carboplatinum (400 mg/m2/day), VP16 (100 mg/m2/day) and ifosfamide (1800 mg /m2/day) | bIFRT 75 Gy (supraclavicular fossa) and 52.5 Gy (posterior region of the neck) |
6 | Bronchus | 2007 | Five cycles of ifosfamide (1200 mg/m2/day) and doxorubicin (37.5 mg/m2/day) given with dexrazoxane as cardioprotectant | 45 Gy |
11 | Paraspinal L4 | 1994 | aCCG 6902, vincristine (1.5 mg/m2), actinomycin (0.15 mg/kg/day) and ifosfamide (1800 mg/m2/day) Subsequent to second debulking, cyclophosphamide (2.2 g/m2), VP16 (100 mg/m2/day). Peripheral hematopoietic stem cell rescue with melphalan (200 mg/m2). | 63.8 Gy |